126 related articles for article (PubMed ID: 37951194)
21. Differential effects of IL-12 on Tregs and non-Treg T cells: roles of IFN-γ, IL-2 and IL-2R.
Zhao J; Zhao J; Perlman S
PLoS One; 2012; 7(9):e46241. PubMed ID: 23029447
[TBL] [Abstract][Full Text] [Related]
22. Efficient Therapeutic Function and Mechanisms of Human Polyclonal CD8
Sun J; Yang Y; Huo X; Zhu B; Li Z; Jiang X; Xie R; Gao L; Sun Y; Fan H; Zhu Y; Yang J
J Immunol Res; 2019; 2019():8575407. PubMed ID: 30915372
[TBL] [Abstract][Full Text] [Related]
23. Th1-like Treg in vitiligo: An incompetent regulator in immune tolerance.
Chen J; Wang X; Cui T; Ni Q; Zhang Q; Zou D; He K; Wu W; Ma J; Wang Y; Guo W; Li C; Li S
J Autoimmun; 2022 Jul; 131():102859. PubMed ID: 35792518
[TBL] [Abstract][Full Text] [Related]
24. A natural compound harmine decreases melanin synthesis through regulation of the DYRK1A/NFATC3 pathway.
Park CH; Kim G; Lee Y; Kim H; Song MJ; Lee DH; Chung JH
J Dermatol Sci; 2021 Jul; 103(1):16-24. PubMed ID: 34030962
[TBL] [Abstract][Full Text] [Related]
25. Rubiginosin B selectively inhibits Treg cell differentiation and enhances anti-tumor immune responses by targeting calcineurin-NFAT signaling pathway.
Geng CA; Chen FY; Zheng JB; Liao P; Li TZ; Zhang XM; Chen X; Chen JJ
Phytomedicine; 2023 Jul; 116():154898. PubMed ID: 37247590
[TBL] [Abstract][Full Text] [Related]
26. Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application.
Henschel P; Landwehr-Kenzel S; Engels N; Schienke A; Kremer J; Riet T; Redel N; Iordanidis K; Saetzler V; John K; Heider M; Hardtke-Wolenski M; Wedemeyer H; Jaeckel E; Noyan F
J Autoimmun; 2023 Jul; 138():103057. PubMed ID: 37224732
[TBL] [Abstract][Full Text] [Related]
27. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
28. Regulatory T cells expanded from HIV-1-infected individuals maintain phenotype, TCR repertoire and suppressive capacity.
Angin M; Klarenbeek PL; King M; Sharma SM; Moodley ES; Rezai A; Piechocka-Trocha A; Toth I; Chan AT; Goulder PJ; Ndung'u T; Kwon DS; Addo MM
PLoS One; 2014; 9(2):e86920. PubMed ID: 24498287
[TBL] [Abstract][Full Text] [Related]
29. Reduced frequency and functional defects of CD4
Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
[TBL] [Abstract][Full Text] [Related]
30. Frequently Increased but Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus.
Zhou L; Cao T; Wang Y; Yao H; Du G; Chen G; Niu X; Tang G
Inflammation; 2016 Jun; 39(3):1205-15. PubMed ID: 27106476
[TBL] [Abstract][Full Text] [Related]
31. FOXP3 promoter demethylation reveals the committed Treg population in humans.
Janson PC; Winerdal ME; Marits P; Thörn M; Ohlsson R; Winqvist O
PLoS One; 2008 Feb; 3(2):e1612. PubMed ID: 18286169
[TBL] [Abstract][Full Text] [Related]
32. In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol.
Schmidt A; Éliás S; Joshi RN; Tegnér J
J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060341
[TBL] [Abstract][Full Text] [Related]
33. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis.
Longhi MS; Hussain MJ; Mitry RR; Arora SK; Mieli-Vergani G; Vergani D; Ma Y
J Immunol; 2006 Apr; 176(7):4484-91. PubMed ID: 16547287
[TBL] [Abstract][Full Text] [Related]
34. Correlation of Blood FoxP3+ Regulatory T Cells and Disease Activity of Atopic Dermatitis.
Li Y; Xu W; Yao J; Cheng H; Sun X; Li L
J Immunol Res; 2019; 2019():1820182. PubMed ID: 31637264
[TBL] [Abstract][Full Text] [Related]
35. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes.
McClymont SA; Putnam AL; Lee MR; Esensten JH; Liu W; Hulme MA; Hoffmüller U; Baron U; Olek S; Bluestone JA; Brusko TM
J Immunol; 2011 Apr; 186(7):3918-26. PubMed ID: 21368230
[TBL] [Abstract][Full Text] [Related]
36. Decreased Circulating T Regulatory Cells in Egyptian Patients with Nonsegmental Vitiligo: Correlation with Disease Activity.
Hegab DS; Attia MA
Dermatol Res Pract; 2015; 2015():145409. PubMed ID: 26788051
[TBL] [Abstract][Full Text] [Related]
37. An IL-27/Lag3 axis enhances Foxp3+ regulatory T cell-suppressive function and therapeutic efficacy.
Do JS; Visperas A; Sanogo YO; Bechtel JJ; Dvorina N; Kim S; Jang E; Stohlman SA; Shen B; Fairchild RL; Baldwin WM; Vignali DA; Min B
Mucosal Immunol; 2016 Jan; 9(1):137-45. PubMed ID: 26013006
[TBL] [Abstract][Full Text] [Related]
38. Regulatory T Cells Require CCR6 for Skin Migration and Local Suppression of Vitiligo.
Essien KI; Katz EL; Strassner JP; Harris JE
J Invest Dermatol; 2022 Dec; 142(12):3158-3166.e7. PubMed ID: 35777498
[TBL] [Abstract][Full Text] [Related]
39. Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice.
Suffner J; Hochweller K; Kühnle MC; Li X; Kroczek RA; Garbi N; Hämmerling GJ
J Immunol; 2010 Feb; 184(4):1810-20. PubMed ID: 20083650
[TBL] [Abstract][Full Text] [Related]
40. T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo.
Tembhre MK; Sharma VK; Sharma A; Chattopadhyay P; Gupta S
Clin Chim Acta; 2013 Sep; 424():27-32. PubMed ID: 23680073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
